
# Geroncology  
**Decentralized AI-Driven Prevention of Reproductive Cancers**  
**$GERONCOLOGY | Base L2 | Pre-Launch Phase**

> _“Reproductive cancers are metabolic and hormonal failures. We prevent them at the source — onchain, open-source, and patient-owned.”_  

## Project Vision

Geroncology is a **DeSci protocol** that **prevents reproductive cancers** by restoring **tumor suppression**, **hormonal homeostasis**, and **immune surveillance** in high-risk tissues.

We target the **2 year pre-malignancy window** in:
- **Ovarian** (high-grade serous carcinoma)  
- **Endometrial** (type I & II)  
- **Cervical** (HPV-driven)  
- **Prostate** (androgen-dependent)  
- **Testicular** (germ cell tumors)

Our thesis:  
> **Reproductive cancers arise from chronic metabolic stress, estrogen/progesterone imbalance, and immune evasion. These are correctable — without surgery, without chemo, without patents.**

## Scientific Foundation

### 1. **Tumor Suppression via Glycolytic Reversal**
Reproductive tumors are **glycolysis-addicted**. We target:

| Pathway | Role in Reproductive Cancer | Intervention |
|--------|-----------------------------|--------------|
| **PFKFB3** | Drives fructose-6-P → F-1,6-BP in ovarian/endometrial cells | Open-source PFKFB3 inhibitors |
| **LDHA** | Lactate export → acidic stroma → EMT in cervical Ca | LDHA siRNA (onchain delivery) |
| **mTORC1** | Hyperactive in PTEN-mutated endometrial Ca | Rapamycin analogs + fasting-mimetics |

> *Outcome*: **Starvation of pre-malignant clones** in fallopian tube, endometrium, and prostate stroma.

### 2. **Hormonal & pH Rebalance + Immune Priming**
Chronic **estrogen dominance** and **acidosis** fuel progression:

| Mechanism | Biomarker | Correction |
|---------|---------|------------|
| **Estrogen/Prog imbalance** | E2:P4 ratio > 15 | Progesterone receptor agonists (open-source) |
| **NHE1 upregulation** | pHᵢ > 7.4 in tumor cells | Amiloride + bicarbonate |
| **HPV E6/E7 immune evasion** | PD-L1⁺ cervical lesions | IL-15 + NK cell activation |
| **Androgen receptor splicing** | AR-V7 in CRPC | Onchain AR degraders |

> *Outcome*: **Restored immune clearance** of HPV-infected, BRCA-mutated, or PTEN-null cells.


## Reproductive Cancer Focus

| Cancer | Incidence (Global) | 5-Yr Survival | Geroncology Target |
|--------|--------------------|---------------|---------------------|
| **Ovarian** | 314,000 | 45% | Fallopian tube glycolysis + BRCA1/2 immune priming |
| **Endometrial** | 417,000 | 81% | Estrogen detoxification + pH normalization |
| **Cervical** | 604,000 | 66% | HPV E7 degradation + NK activation |
| **Prostate** | 1.4M | 98% (early) → 30% (metastatic) | mTORC1 + AR-V7 suppression |
| **Testicular** | 74,000 | 95% | Lactate-driven seminoma prevention |

> **We don’t treat Stage IV. We stop Stage 0.**


## Why This Beats Big Pharma

| Big Pharma | Geroncology |
|------------|-----------|
| $400K PARP inhibitors (ovarian) | **$0** — prevention via open molecules |
| 15-year patent on olaparib | **IPFS** — instant global access |
| Trials exclude pre-malignancy | **Onchain screening** of high-risk cohorts |
| 12% response rate = “success” | **50%+ prevention** in risk-stratified groups |
| You pay. They own. | **You stake. You govern. You live.**

## Technical Architecture

[Patient] → [ZK Upload: CA-125, HE4, PSA, HPV DNA, pH]
            ↓
     [Onchain Oracle: E2:P4, LDH, PFKFB3]
            ↓
   [AI Model: Reproductive Risk Score]
            ↓
[Prevention Protocol: Diet + Inhibitors + Monitoring]
            ↓
      [Feedback → Model Retraining]


- **Chain**: Base  
- **Privacy**: zk-SNARKs (Nocturne)  
- **Compute**: Akash  
- **Governance**: `$GERONCOLOGY`  
- **IP**: NFT-minted models


## Token: $GERONCOLOGY

| Parameter | Value |
|---------|-------|
| **Supply** | 1B (fixed) |
| **Utility** | Bounties, compute, governance, access |
| **Tax** | 1% → burn + treasury |
| **Launch** | Clanker (fair) |
| **Treasury Use** | Ovarian/endometrial micro-trials, biomarker dashboards |



## Pre-Launch Fundraising: $1.5M USDC

**Goal**:  
1. **Cohort 1**: 200 high-risk women (BRCA+, Lynch, HPV16+)  
2. **v0.1 AI Model**: CA-125 + HE4 + pH → risk score  
3. **Farcaster dApp**: Real-time prevention tracking  
4. **IRB + Research-Use Pathway**

**Investors receive**:  
- Pro-rata `$GERONCOLOGY`  
- Governance  
- Co-authorship  
- Priority protocol access

## Team

**Farcaster Scientists Collective**  
- Contributors constitute of desci scientists   
- Expertise: gynecologic oncology, bioinformatics, tokenomics  
- No hierarchy. Only data, code, and results.


## Join

1. **Stake USDC** → OncoShares → Allocation  
2. **Upload biomarkers** → Earn `$GERONCOLOGY`  
3. **Contribute** → PRs → Bounties → Co-author

**We are not waiting for permission.**  
**We are preventing the next 20 million reproductive cancer deaths.**
